Germline BRCA1/2 status and chemotherapy response score in high-grade serous ovarian cancer.
Morgan RD, Wang X, Barnes BM, Spurgeon L, Carrot A, Netto D, Hasan J, Mitchell C, Salih Z, Desai S, Shaw J, Winter-Roach B, Schlecht H, Burghel GJ, Clamp AR, Edmondson RJ, You B, Evans DGR, Jayson GC, Taylor SS.
Morgan RD, et al.
Br J Cancer. 2024 Nov 16. doi: 10.1038/s41416-024-02874-6. Online ahead of print.
Br J Cancer. 2024.
PMID: 39550490